PARP2 and experimental autoimmune encephalomyelitis: Furthermore, in experimental autoimmune encephalomyelitis, PARP2 knockout (PARP2–/–) mice demonstrate delayed disease onset and markedly reduced T helper 17 (Th17) lymphocytes, thus leading to attenuated central nervous system inflammation [172, 173].